The physiological state of carrying developing offspring from implantation through parturition, representing the most extreme example of mammalian immune tolerance where the maternal immune system must accept semi-allogeneic tissue expressing paternal antigens. Pregnancy orchestrates coordinated neuroendocrine-immune shifts including Th2 cytokine dominance, T regulatory cells expansion, dramatic hormonal elevation (Progesterone 150-200 ng/mL by third trimester, oestrogen up to 40 ng/mL), and bidirectional cellular exchange creating lifelong Microchimerism.
Think of pregnancy as negotiating a long-term tenant agreement in a building (the uterus) where the tenant (fetus) is only 50% related to the landlord (mother). Before signing the lease, the landlord needs to see the tenant's ID papers multiple times through regular visits (seminal fluid exposure during pre-conception intercourse) β each visit containing reference documents (paternal antigens, TGF-beta, IL-10, Prostaglandins) that train the building's security team (immune system) to recognize and accept this specific tenant. Once the tenant moves in, the building manager (Progesterone) issues standing orders: "This person is authorized β do not evict." Security guards (Th1 cells, NK cells) are reassigned to maintenance and support roles rather than threat detection. The tenant actually renovates part of the building (Trophoblastic Implantation) by breaking through walls (maternal spiral arteries) to install their own plumbing system (placental circulation). Some of the tenant's contractors (fetal cells) stay in the building permanently after move-out, occasionally helping with repairs decades later. If the security team doesn't get enough advance exposure to the ID papers (preeclampsia), or if they refuse to stand down (recurrent miscarriage), eviction proceedings begin.
Pregnancy requires coordinated immune reprogramming across multiple systems:
Pre-conception tolerance induction:
Seminal fluid exposure β dendritic cell uptake of paternal antigens + TGF-beta (1-50 ng/mL) + IL-10 (5-20 pg/mL) + Prostaglandin E2 (PGE2) β T regulatory cells (Treg) priming in uterine lymph nodes β FoxP3+ Treg expansion β suppression of Th1 and cytotoxic responses to paternal HLA antigens
Implantation phase (day 6-12):
Blastocyst adhesion β trophoblast expression of HLA-G (non-classical MHC) β binding to KIR receptors on uterine NK cells β decidual NK cell conversion from cytotoxic to angiogenic phenotype β VEGF and PlGF secretion β spiral artery remodeling β reduced IL-12 and IFN-Ξ³ β prevented Th1 activation
First trimester immune shift:
Progesterone (20-40 ng/mL) β binding to Progesterone-induced blocking factor (PIBF) β Th2 cytokine promotion (IL-4, IL-10) β suppression of Th1 cytokines (IFN-Ξ³, IL-2, TNF-Ξ±) β reduced cell-mediated immunity β fetal tolerance
Oestrogen (2-30 ng/mL) β upregulation of T regulatory cells β increased TGF-Ξ² production β suppression of Th1/Th17 responses
Second/third trimester maintenance:
Progesterone peaks (150-200 ng/mL) β genomic effects via Progesterone Receptor (PR) β expression of immunomodulatory proteins (Gal-9, HO-1) β sustained Treg expansion
HLA antigens-G expression by extravillous trophoblasts β binding to ILT2/ILT4 receptors on maternal immune cells β inhibitory signaling β prevented cytotoxic attack
IDO (indoleamine 2,3-dioxygenase) expression in placenta β tryptophan depletion β T cell anergy + kynurenine pathway activation β Treg differentiation
Microchimerism establishment:
Bidirectional cell trafficking across placenta β fetal cells in maternal circulation (1-6 cells/mL maternal blood) β long-term engraftment in maternal tissues (lung, thyroid, liver, brain) β persistence for decades β potential autoimmune modulation or repair functions
Metabolic demands:
Trophoblastic Implantation phase (weeks 6-12) β deep endometrial invasion β high ATP requirements β vulnerability to mitochondrial dysfunction
Fetal brain development β DHA (docosahexaenoic acid) transfer rate 50-60 mg/day in third trimester β maternal Omega-3 store depletion β 50% reduction in maternal DHA status by delivery β postpartum depression risk if unrepleted
Corpus luteum β Progesterone production (weeks 0-10) β placental takeover (week 10+) β requires adequate cholesterol substrate
Preeclampsia as tolerance failure:
Inadequate sexual exposure to paternal antigens pre-conception β insufficient Treg priming β incomplete tolerance β placental oxidative stress β release of sFlt-1 (soluble VEGF receptor) β endothelial dysfunction β hypertension (BP >140/90 mmHg) + proteinuria (>300 mg/24h). New partner pregnancy carries 10x higher preeclampsia risk. Intervention: pre-conception counseling on barrier-free intercourse frequency (minimum 3 months regular exposure).
Recurrent pregnancy loss:
Th1 dominance β IFN-Ξ³ >50 pg/mL, TNF-Ξ± >20 pg/mL β cytotoxic attack on trophoblast β miscarriage before week 12. Also seen in Autoimmunity conditions (Hashimoto's thyroiditis, Coeliac disease) where baseline Th1 activation prevents shift to Th2. Intervention: address underlying immune activation, optimize Vitamin D (>40 ng/mL for Treg function), consider low-dose Aspirin 81 mg/day (promotes Lipid mediator class switching toward Resolvins).
Postpartum depression mechanism:
Pregnancy-induced DHA depletion β reduced neuronal membrane fluidity β impaired serotonin receptor function β mood vulnerability. Corpus Callosum Function metabolic demands increase during pregnancy β white matter susceptibility to nutritional deficits β cognitive symptoms. Inflammatory rebound after delivery β shift from Th2 back to Th1 β IL-6 elevation β Depression. Intervention: DHA supplementation 1-2 g/day throughout pregnancy and 6 months postpartum, anti-inflammatory diet, screening for Iron deficiency (Ferritin <30 ng/mL).
Evolutionary mismatch context:
Modern pregnancy occurs in context of Evolutionary mismatch β reduced pathogen exposure (Hygiene hypothesis), barrier contraception preventing antigen priming, delayed first pregnancy (age >30 = 2x preeclampsia risk vs age 20-25), nutrient depletion from frequent pregnancies without adequate recovery intervals. Hunter-Gatherer Phenotype expectation: first pregnancy age 16-19, 3-4 year birth spacing, continuous infant carrying (skin-to-skin contact), extended breastfeeding (2-4 years) allowing maternal nutrient repletion.
Clinical assessment priorities: